Pass the CREATES Act to End Manipulative Practices That Cost Our Patients Billions
Since Apotex’s inception over 40 years ago, our company has focused on a sole purpose: improving access to affordable, innovative and high-quality medications. Over the years, we have seen the generics industry weather a number of challenges caused by legislative and regulatory changes in the markets in which we operate. The industry has also benefited […]
AAM Statement on Senate Judiciary Committee Vote on CREATES Act
WASHINGTON DC (June 14, 2018) – Today, the Senate Judiciary Committee, on a strong bipartisan basis, has taken a critical first step toward making real progress on the problem that U.S. patients care the most about: high drug prices. The full Senate and the House should follow the Judiciary Committee’s lead and pass a strong […]
#EndtheShenanigans, Says Gottlieb
Dr. Scott Gottlieb, Commissioner of Food and Drugs, has adopted a bold stance on behalf of patient access to affordable medicines. In particular, he is targeting REMS abuse — by which some bad actors prevent generic firms from purchasing the doses of a branded drug that they need to run their studies — for the way […]
Support the CREATES Act and Help Patients Win
“The objective is to win: fairly, squarely, decently, win by the rules, but still win.” – Vince Lombardi When it comes to prescription medicines, patients win when companies innovate new cures and treatments. Patients also win when more affordable generic versions of those medicines enter the market. Unfortunately, some brand manufacturers aren’t playing by the […]
The CREATES Act – A Conservative Market-based Solution to Lower Drug Prices
Help Pass the CREATES Act
Anticompetitive practices prevent patients from accessing the generic and biosimilar medicines they need. Congress is currently considering a fix, the Creating and Restoring Equal Access to Equivalent Samples (“CREATES”) Act. Encourage your members of Congress to pass this important bill that will bring down costs and increase patient access to life-saving medicines. Watch this CBS […]
Expediting Approval of Generic Applications and Stopping REMS Abuse Among Top Priorities for Nation’s Leading Patient Advocacy Group
The National Health Council Supports Generic Drugs as a Way to Reduce Health Care Costs WASHINGTON, DC (April 27, 2017) – The Association for Accessible Medicines (AAM) today applauded the National Health Council (NHC) for supporting polices to reduce patient health care costs and increase patient access to affordable medicines by expediting the approval of […]
REMS Abuse Impeding Patient Access to Generic Drugs – Myths and Facts
Background – What are REMS and What is Current Law? Under the Food and Drug Administration Amendments Act (FDAAA) of 2007, FDA can require manufacturers of drugs with known risks to develop a Risk Evaluation and Mitigation Strategies (REMS) program. REMS programs are designed to ensure that the benefits of a drug or biologic outweigh […]
AAM Group Letter of Support for FAST Generics Act
April 6, 2017 The Honorable David McKinley The Honorable Peter Welch Dear Congressmen McKinley and Welch: As stakeholders firmly committed to fostering patient access to affordable medicines and pharmaceutical competition, we would like to thank you for introducing the Fair Access for Safe and Timely (“FAST”) Generics Act. The bill would provide a clear solution […]
